HEALTH● LOW5d ago · Aug 27, 2026, 6:33 AM
AbbVie files for EMA approval of Skyrizi for Crohn’s disease treatment
Seeking Alpha Tech
AbbVie has submitted an application to the European Medicines Agency for approval of Skyrizi as a treatment for Crohn's disease. This step is part of the regulatory process for new pharmaceutical products.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH26m agoBlood Bank of Delmarva Blood Drivewmdt.com · United StatesHEALTH41m agoJapan’s deadliest delicacy is getting more dangerousSouth China Morning PostHEALTH56m agoWhat it like to live with – and lose – a loved one with CTEwcvb.com · United StatesHEALTH1h agoAfrica grows more tobacco, spends more on imported cigarettes — WHOVanguard Nigeria